NCT04879550View on ClinicalTrials.gov

Prospective Investigation of Antithrombin III Deficiency in Adult Patients With ECMO

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

January 1, 2022

Study Completion Date

March 1, 2022

Conditions
Antithrombin III DeficiencyExtracorporeal Membrane Oxygenation Complication
Interventions
DIAGNOSTIC_TEST

Antithrombin III

Antithrombin III deficiency causes thrombosis. Is thrombosis in ECMO patients related to Antithrombin III deficiency? Groups with and without thrombosis will be separated and whether it is related to Antithrombin III deficiency will be evaluated.

Trial Locations (1)

34668

Istanbul Dr.Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul

All Listed Sponsors
lead

Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital

OTHER

NCT04879550 - Prospective Investigation of Antithrombin III Deficiency in Adult Patients With ECMO | Biotech Hunter | Biotech Hunter